Track: CME Session

SESSION 11: SPECIAL TOPICS

Moderator(s)

• 

  Sylvie Negrier, MD PhD (she/her/hers)

  Medical Oncologist
  Centre Leon Bérard, Lyon I University
  Centre Léon Bérard & Lyon University
  Lyon Cedex 08, France
• 

  Nizar Tannir, MD FACP (he/him/his)

  Professor
  University of Texas MD Anderson Cancer Center
  UT MD Anderson Cancer Center
  Houston, Texas, United States

Presentations:

• 14:41 – 14:42 GMT

  Introduction to Session 11
  

  Moderator: Sylvie Negrier, MD PhD (she/her/hers) – Centre Leon Bérard, Lyon I University
• 14:42 – 14:52 GMT

  Modulating gut microbiome to influence outcomes with IO
  

  Speaker: Nazli Dizman, MD – Yale New Haven Hospital
• 14:52 – 15:02 GMT

  HIF2a in VHL and beyond
  

  Speaker: Tian Zhang, MD, MHS (she/her/hers) – University of Texas Southwestern Medical Center
• 15:02 – 15:12 GMT

  Novel therapeutics *except HiF2a
  

  Speaker: Thomas Powles, MBBS, MRCP, MD (he/him/his) – Barts Cancer Institute
• 15:12 – 15:22 GMT

  Therapy of patients with and of brain metastases
  

  Speaker: Sylvie Negrier, MD PhD (she/her/hers) – Centre Leon Bérard, Lyon I University
• 15:22 – 15:35 GMT

  Session 11 Q&A
  

  Moderator: Sylvie Negrier, MD PhD (she/her/hers) – Centre Leon Bérard, Lyon I University

  Moderator: Nizar M. Tannir, MD FACP (he/him/his) – University of Texas MD Anderson Cancer Center